1. Liver Cancer Study Group of Japan. 1990; Primary liver cancer in Japan: clinicopathologic features and results of surgical treatment. Ann Surg. 211:277–87.
2. Kim HR, Rha SY, Cheon SH, Roh JK, Park YN, Yoo NC. 2009; Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma. Ann Oncol. 20:780–7. DOI:
10.1093/annonc/mdn702. PMID:
19179547.
3. Mehrabi A, Kashfi A, Fonouni H, Schemmer P, Schmied BM, Hallscheidt P, et al. 2006; Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy. Cancer. 107:2108–21. DOI:
10.1002/cncr.22225. PMID:
17019735.
4. Na BG, Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, et al. 2021; Prognosis of hepatic epithelioid hemangioendothelioma after living donor liver transplantation. Korean J Transplant. 35:15–23. DOI:
10.4285/kjt.20.0049. PMID:
35769618. PMCID:
PMC9235330.
5. Chavhan GB, Siddiqui I, Ingley KM, Gupta AA. 2019; Rare malignant liver tumors in children. Pediatr Radiol. 49:1404–21. DOI:
10.1007/s00247-019-04402-8. PMID:
31620842.
6. Otte JB, de Ville de Goyet J, Reding R. 2005; Liver transplantation for hepatoblastoma: indications and contraindications in the modern era. Pediatr Transplant. 9:557–65. DOI:
10.1111/j.1399-3046.2005.00354.x. PMID:
16176410.
7. Spunt SL, Lobe TE, Pappo AS, Parham DM, Wharam MD Jr, Arndt C, et al. 2000; Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma. J Pediatr Surg. 35:309–16. DOI:
10.1016/S0022-3468(00)90030-7. PMID:
10693686.
8. Meza JL, Anderson J, Pappo AS, Meyer WH. Children’s Oncology Group. 2006; Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children’s Oncology Group. J Clin Oncol. 24:3844–51. DOI:
10.1200/JCO.2005.05.3801. PMID:
16921036.
9. Cecchetto G, Bisogno G, Treuner J, Ferrari A, Mattke A, Casanova M, et al. 2003; Role of surgery for nonmetastatic abdominal rhabdomyosarcomas: a report from the Italian and German Soft Tissue Cooperative Groups Studies. Cancer. 97:1974–80. DOI:
10.1002/cncr.11285. PMID:
12673726.
11. Austin MT, Leys CM, Feurer ID, Lovvorn HN 3rd, O'Neill JA Jr, Pinson CW, et al. 2006; Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database. J Pediatr Surg. 41:182–6. DOI:
10.1016/j.jpedsurg.2005.10.091. PMID:
16410130.
12. Shen CH, Dong KR, Tao YF, Chen G, Li RD, Zhang QB, et al. 2017; Liver transplantation for biliary rhabdomyosarcoma with liver metastasis: report of one case. Transplant Proc. 49:185–7. DOI:
10.1016/j.transproceed.2016.11.028. PMID:
28104133.
13. Paganelli M, Beaunoyer M, Samson Y, Dal Soglio D, Dubois J, Lallier M, et al. 2014; A child with unresectable biliary rhabdomyosarcoma: 48-month disease-free survival after liver transplantation. Pediatr Transplant. 18:E146–51. DOI:
10.1111/petr.12279. PMID:
24815678.
14. Minn AY, Lyden ER, Anderson JR, Million L, Arndt CA, Brown K, et al. 2010; Early treatment failure in intermediate-risk rhabdomyosarcoma: results from IRS-IV and D9803--a report from the Children’s Oncology Group. J Clin Oncol. 28:4228–32. DOI:
10.1200/JCO.2010.29.0247. PMID:
20713850. PMCID:
PMC2953975.